 | Up a level |
Garbe, C; Peris, K; Soura, E; Forsea, A M; Hauschild, A; Arenbergerova, M; Bylaite, M; Del Marmol, V; Bataille, V; Samimi, M; Gandini, S; Saiag, P; Eigentler, T K; Lallas, A; Zalaudek, I; Lebbe, C; Grob, J-J; Hoeller, C; Robert, C; Dréno, B; ... (2020). The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force. Journal of the European Academy of Dermatology and Venereology : JEADV, 34(10), pp. 2183-2197. Wiley 10.1111/jdv.16849
Eisen, T; Sternberg, C; Robert, C; Mulders, P; Pyle, L; Zbinden, S; Izzedine, H; Escudier, B (2012). Targeted therapies for renal cell carcinoma: review of adverse event management strategies. Journal of the National Cancer Institute JNCI, 104(2), pp. 93-113. Cary, N.C.: Oxford University Press 10.1093/jnci/djr511
